99 related articles for article (PubMed ID: 24216617)
1. Changes in substance P and NK1 receptor immunohistochemistry following human spinal cord injury.
Leonard AV; Manavis J; Blumbergs PC; Vink R
Spinal Cord; 2014 Jan; 52(1):17-23. PubMed ID: 24216617
[TBL] [Abstract][Full Text] [Related]
2. Substance P as a mediator of neurogenic inflammation after balloon compression induced spinal cord injury.
Leonard AV; Thornton E; Vink R
J Neurotrauma; 2013 Nov; 30(21):1812-23. PubMed ID: 23924052
[TBL] [Abstract][Full Text] [Related]
3. NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
Leonard AV; Thornton E; Vink R
PLoS One; 2014; 9(5):e98364. PubMed ID: 24859234
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the role of substance P in the growth of brain tumors.
Harford-Wright E; Lewis KM; Vink R; Ghabriel MN
Neuroscience; 2014 Mar; 261():85-94. PubMed ID: 24374326
[TBL] [Abstract][Full Text] [Related]
5. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Donkin JJ; Nimmo AJ; Cernak I; Blumbergs PC; Vink R
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1388-98. PubMed ID: 19436311
[TBL] [Abstract][Full Text] [Related]
6. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
Heng YJ; Saunders CI; Kunde DA; Geraghty DP
Regul Pept; 2011 Apr; 167(2-3):250-8. PubMed ID: 21329730
[TBL] [Abstract][Full Text] [Related]
7. The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury.
Leonard AV; Vink R
Acta Neurochir Suppl; 2013; 118():303-6. PubMed ID: 23564154
[TBL] [Abstract][Full Text] [Related]
8. The cellular inflammatory response in human spinal cords after injury.
Fleming JC; Norenberg MD; Ramsay DA; Dekaban GA; Marcillo AE; Saenz AD; Pasquale-Styles M; Dietrich WD; Weaver LC
Brain; 2006 Dec; 129(Pt 12):3249-69. PubMed ID: 17071951
[TBL] [Abstract][Full Text] [Related]
9. Substance P in traumatic brain injury.
Donkin JJ; Turner RJ; Hassan I; Vink R
Prog Brain Res; 2007; 161():97-109. PubMed ID: 17618972
[TBL] [Abstract][Full Text] [Related]
10. A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
Turner RJ; Helps SC; Thornton E; Vink R
Brain Res; 2011 Jun; 1393():84-90. PubMed ID: 21466790
[TBL] [Abstract][Full Text] [Related]
11. [Observation of neuropeptides in bladder after spinal cord injury in rats].
LI RZ; ZHOU MW; ZENG FS
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1058-61. PubMed ID: 22781650
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina.
Casini G; Dal Monte M; Fornai F; Bosco L; Willems D; Yang Q; Zhou ZJ; Bagnoli P
Neuroscience; 2004; 124(1):147-60. PubMed ID: 14960347
[TBL] [Abstract][Full Text] [Related]
13. NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke.
Turner RJ; Vink R
Neuropeptides; 2014 Oct; 48(5):267-72. PubMed ID: 25151181
[TBL] [Abstract][Full Text] [Related]
14. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
BMC Neurol; 2007 Jun; 7():17. PubMed ID: 17594482
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
Harford-Wright E; Lewis KM; Ghabriel MN; Vink R
PLoS One; 2014; 9(5):e97002. PubMed ID: 24818961
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus.
Commons KG; Valentino RJ
J Comp Neurol; 2002 May; 447(1):82-97. PubMed ID: 11967897
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of tyrosine kinase (Trka, Trkb) receptor expression and phosphorylation in lumbosacral dorsal root ganglia after chronic spinal cord (T8-T10) injury.
Qiao L; Vizzard MA
J Comp Neurol; 2002 Jul; 449(3):217-30. PubMed ID: 12115676
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of SP- and 5HT-containing terminals in lamina II of rat spinal cord following dorsal rhizotomy: quantitative EM-immunocytochemical studies.
Zhang B; Goldberger ME; Murray M
Exp Neurol; 1993 Sep; 123(1):51-63. PubMed ID: 7691648
[TBL] [Abstract][Full Text] [Related]
20. [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.
Griffante C; Carletti R; Andreetta F; Corsi M
Br J Pharmacol; 2006 May; 148(1):39-45. PubMed ID: 16501582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
